PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 35038965-2 2022 INTRODUCTION: The most common altered signaling found in aggressive iodine-refractory thyroid cancers derived from follicular cells (RAI-TC) are RTK, MAPK, PI3K, WNT, BRAF, RAS, RET, and TP53. Iodine 68-74 tumor protein p53 Homo sapiens 187-191 10910962-1 2000 Simultaneous labelling of 17cen and the p53 locus by multicolour FISH was used to monitor radioactive iodine-induced structural and numerical chromosome abnormalities in buccal cells from 29 hyperthyroidism and thyroid cancer patients sampled before and after therapeutic treatment. Iodine 102-108 tumor protein p53 Homo sapiens 40-43 25515142-12 2015 In addition, iodine-131 may upregulate GADD45 mRNA expression in HTori-3 cells, resulting in G2/M phase arrest in a p53-independent pathway. Iodine 13-19 tumor protein p53 Homo sapiens 116-119 28892665-6 2017 On the other hand, significantly greater GPBB immunoreactivity was observed in the basal and parabasal layers of iodine-unstained epithelium, where higher positivity for p53 and Ki67 was also showed. Iodine 113-119 tumor protein p53 Homo sapiens 170-173 26527121-8 2015 P53 expression in the HuH7 and HepG2 cell lines increased after internal and external irradiation with iodine-131. Iodine 103-109 tumor protein p53 Homo sapiens 0-3 28714021-2 2017 We found that iodine-131 reduced cell proliferation, induced apoptosis, induced p53, PIDD, t-BID (mitochondria) protein expression, suppressed cytochrome c (mitochondria) protein expression, and increased Bax protein expression, and promoted caspase-2, -3 and -9 expression levels in human cardiac muscle cells. Iodine 14-20 tumor protein p53 Homo sapiens 80-83 28714021-3 2017 Meanwhile, si-p53 inhibited the effects of iodine-131 on the reduction in cell proliferation and induction of apoptosis in human cardiac muscle cells through regulation of Bax/cytochrome c/caspase-3 and PIDD/caspase-2/t-BID/cytochrome c/caspase-3 signaling pathway. Iodine 43-49 tumor protein p53 Homo sapiens 14-17 25033896-11 2014 CONCLUSIONS: The inhibitory mechanisms of iodine on CRC acted through an increase in the level of p53 and a decrease in the level of VEGF, resulting in a decrease of MVD. Iodine 42-48 tumor protein p53 Homo sapiens 98-101 24764719-3 2014 Here, we report the case of a woman with TP53 mutation who was treated with adjuvant pelvic rt for stage ib uterine leiomyosarcoma in 2000, with radioactive iodine for papillary thyroid cancer in 2001, and with palliative rt to the humerus in 2010 for metastatic uterine leiomyosarcoma. Iodine 157-163 tumor protein p53 Homo sapiens 41-45 22829208-8 2013 Iodine-negative epithelium presented significantly higher immunoreactions for P53 and GLUT 1 in basal, parabasal, and superficial layers, respectively, whereas the reaction for Ki67 in the superficial layer was higher than that in iodine-positive epithelium (Wilcoxon signed-rank test, P < 0.05). Iodine 0-6 tumor protein p53 Homo sapiens 78-81 20138958-0 2010 Iodine induces apoptosis via regulating MAPKs-related p53, p21, and Bcl-xL in thyroid cancer cells. Iodine 0-6 tumor protein p53 Homo sapiens 54-57 20138958-6 2010 Iodine treatment decreased the level of mutant p53 including the R273H mutant that possesses anti-apoptotic features, but increased the p21 level. Iodine 0-6 tumor protein p53 Homo sapiens 47-50 20138958-8 2010 Moreover, iodine transiently activated the subfamily members of mitogen activated protein kinases (MAPKs) (ERK1/2, p38 and JNK1/2) which contribute to modulate p53, p21 and Bcl-xL expression. Iodine 10-16 tumor protein p53 Homo sapiens 160-163 20138958-10 2010 Collectively, iodine-induced apoptotic pathway is involved in the activation of MAPKs-related p21, Bcl-xL and mutant p53 regulation. Iodine 14-20 tumor protein p53 Homo sapiens 117-120 22027149-2 2011 Previously, we showed that molecular Iodine (I(2)) induces apoptosis in hormone responsive MCF-7 breast cancer cells, and non-apoptotic cell death in ER(-ve)-p53 mutant MDA-MB231 cells (Shrivastava, 2006). Iodine 37-43 tumor protein p53 Homo sapiens 158-161